Wednesday, June 13, 2012

Abbott opens nutrition R&D center in India with Biocon subsidiary

Drug firm Abbott today opened its first nutrition research and development center in the country in collaboration with Biocon's subsidiary Syngene.

The R&D center aims to focus on development of affordable nutrition products and enable the expansion of Abbott's nutrition product portfolio in India.

The center was inaugurated in Bangalore by Advisor to the Prime Minister on Public Information Infrastructure & Innovations and Chairman of the National Innovation Council Sam Pitroda.

Abbott selected Syngene to provide a science-based research and innovation team to work closely with Abbott researchers, the company said.

More than 50 researchers and scientists will be based at the Abbott Nutrition R&D center at Biocon Park in Bangalore.

The R&D center will focus on the developing nutrition products for maternal and child nutrition and diabetes care by using local expertise to focus on product design, development and delivery specifically for the Indian consumers, it added.

Commenting on the development Abbott Global Nutrition Executive Vice President John Landgraf said: "This new R&D center in Bangalore will play a pivotal role in getting us even closer to the Indian market and addressing the nutritional requirements of the Indian consumer."

Among the products being developed for the Indian market are meal complements for diabetics and pre-diabetics, Abbott said.

"The combined market insights and nutrition science expertise of our two organisations will enable us to address the healthcare and nutritional challenges of an emerging economy like India across a diverse range of diseases that straddle both infectious and chronic maladies," Biocon CMD Kiran Mazumdar Shaw said on the development.

The center will address local taste and texture preferences with new flavors and formulations, it added.

No comments:

Post a Comment